- Full Year 2024 Terumo Corp Earnings Presentation TranscriptMay 14, 2024
- Q3 2024 Terumo Corp Earnings Presentation TranscriptFeb 07, 2024
- Q2 2024 Terumo Corp Earnings Presentation TranscriptNov 14, 2023
- Q1 2024 Terumo Corp Earnings Presentation TranscriptAug 09, 2023
- Full Year 2023 Terumo Corp Earnings Call TranscriptMay 15, 2023MXN264.95Earnings
- Q3 2023 Terumo Corp Earnings Call TranscriptFeb 09, 2023MXN278.57Earnings
- Q2 2023 Terumo Corp Earnings Call TranscriptNov 10, 2022MXN290.71Earnings
- Q1 2023 Terumo Corp Earnings Call TranscriptAug 09, 2022MXN307.02Earnings
- Full Year 2022 Terumo Corp Earnings Call TranscriptMay 12, 2022MXN307.02Earnings
- Q3 2022 Terumo Corp Earnings Call TranscriptFeb 09, 2022MXN376.42Earnings
- Terumo Corp New Growth Strategy Briefing TranscriptDec 16, 2021
- Q2 2022 Terumo Corp Earnings Call TranscriptNov 04, 2021Earnings
- Q1 2022 Terumo Corp Earnings Call TranscriptAug 04, 2021Earnings
- Full Year 2021 Terumo Corp Earnings Call TranscriptMay 12, 2021Earnings
- Q3 2021 Terumo Corp Earnings Call TranscriptFeb 04, 2021Earnings
- Q2 2021 Terumo Corp Earnings Call TranscriptNov 05, 2020Earnings
- Q1 2021 Terumo Corp Earnings Call TranscriptAug 06, 2020Earnings
- Full Year 2020 Terumo Corp Earnings Call TranscriptMay 18, 2020Earnings
- Q3 2020 Terumo Corp Earnings Call TranscriptFeb 06, 2020Earnings
- Q2 2020 Terumo Corp Earnings Presentation TranscriptNov 07, 2019
- Q1 2020 Terumo Corp Earnings Call TranscriptAug 08, 2019Earnings
- Full Year 2019 Terumo Corp Earnings Presentation TranscriptMay 09, 2019
Q1 2023 Terumo Corp Earnings Call Transcript
I am the CFO, Muto. I will now explain the first quarter results for the fiscal year ending March 2023.
First, the highlights of this earnings announcement. Revenue grew positively year-on-year and was the highest ever in a quarter for all 3 companies. Recovery in health care demand, including a number of procedures in addition to FX contribution resulted in double-digit growth in all regions outside of Japan. All regions grew positively year-on-year even when excluding FX impact. In profit, there was impact from inflation, but increased revenue resulted in 8% gross profit growth. Simultaneously, sales promotion, R&D and other activities resumed more than they had in the same quarter of the previous year when they were still partially limited by COVID-19. As a result, operating profit was minus 16% year-on-year, but it was positive 41% compared to the fourth quarter of the previous period that directly preceded it. Progress towards the annual guidance is 25% in sales revenue and 23% in operating
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)